Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Fatty liver diseases, such as non-alcoholic fatty liver disease (NAFLD), are global health disparities, particularly in the United States, as a result of cultural eating habits and lifestyle. Pathological studies on NAFLD have been mostly focused on hepatocytes and other inflammatory cell types; however, the impact of other biliary epithelial cells (i.e., cholangiocytes) in the promotion of NAFLD is growing. This review article will discuss how cholestatic injury and cholangiocyte activity/ductular reaction influence NAFLD progression. Furthermore, this review will provide informative details regarding the fundamental properties of cholangiocytes and bile acid signaling that can influence NAFLD. Lastly, studies relating to the pathogenesis of NAFLD, cholangiopathies, and ductular reaction will be analyzed to help gain insight for potential therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)33041-7 · Cited by 1,277
Chávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.012 · Cited by 482 · cited 3×
“According to recent research, ductular reaction could be a potential target for liver disease therapies [22], and ductular reaction has been implicated in worsening liver fibrosis [22,27,28].”
BackgroundDeterminants of Fibrosis Progression and Regression in NASH
Schuppan, D., Surabattula, R., & Wang, X. Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.012 · Cited by 479 · cited 1×
“As NAFLD patients have increased free fatty acid (FFA) concentrations, hepatocyte lipoapoptosis is a typical feature of NAFLD and is a major determinant of fibrogenesis during disease progression [57,72].”
BackgroundBile acid nuclear receptor FXR and digestive system diseases
Ding, L., Yang, L., Wang, Z., & Huang, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.004 · Cited by 477 · cited 2×
“jugated and unconjugated hydrophobic bile acids, but not hydrophilic bile acids [38].”
BackgroundRole of CFTR in epithelial physiology
Saint-Criq, V., & Gray, M. A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2391-y · Cited by 433
Ductular reaction in liver diseases: pathological mechanisms and translational significances
Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G. (2019) · Hepatology · doi:10.1002/hep.30150 · Cited by 423 · cited 6×
“According to recent research, ductular reaction could be a potential target for liver disease therapies [22], and ductular reaction has been implicated in worsening liver fibrosis [22,27,28].”
BackgroundInfluentialSelf-citationSyn, W.-K., Choi, S. S., Liaskou, E., Karaca, G. F., Agboola, K. M., Oo, Y. H., Mi, Z., Pereira, T. A., Zdanowicz, M., Malladi, P., et al. (2011) · Hepatology · doi:10.1002/hep.23998 · Cited by 275 · cited 5×
“These findings were recapitulated in a mouse NASH model, and the authors further found that loss of OPN reduced liver fibrosis in their model [107].”
BackgroundInfluentialTabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology · doi:10.1002/hep.26993 · Cited by 241
Boyer, J. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00519.x · Cited by 124 · cited 18×
“While AMA-positive NASH patients did not pre- sent with bile duct injury, it is hypothesized that detection of serum AMA may present years to decades before cholestatic or PBC manifestation [61], alluding to an interaction between bile duct damage and NAFLD in a subset of patients.”
BackgroundInfluentialHepatic senescence, the good and the bad
Huda, N., Liu, G., Hong, H., Yan, S., Khambu, B., & Yin, X.-M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5069 · Cited by 100 · cited 1×
“Further, damaged large cholangiocytes can become senescent and enter a senescence-associated secretory phenotype (SASP), whereby they release inflammatory mediators that promote further damage [9].”
BackgroundSaturated free fatty acids induce cholangiocyte lipoapoptosis
Natarajan, S. K., Ingham, S. A., Mohr, A. M., Wehrkamp, C. J., Ray, A., Roy, S., Cazanave, S. C., Phillippi, M. A., & Mott, J. L. (2014) · Hepatology · doi:10.1002/hep.27175 · Cited by 62 · cited 6×
“not related to alcohol consumption, but could potentially progress into later stages of liver diseases, such as NASH, hepatic fibrosis, and cirrhosis [57].”
BackgroundInfluentialZhao, L., Westerhoff, M., Pai, R. K., Choi, W.-T., Gao, Z.-H., & Hart, J. (2018) · Modern Pathology · doi:10.1038/modpathol.2017.115 · Cited by 44 · cited 3×
“related study, it was found that centrilobular ductular reaction significantly correlated with necroinflammation and fibrosis scores in NASH patients [28]; however, it would be interesting to compare the impact of periportal versus centrilobular ductular reaction to”
BackgroundChiba, M., Sasaki, M., Kitamura, S., Ikeda, H., Sato, Y., & Nakanuma, Y. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2011.090175 · Cited by 43 · cited 3×
“Another study fo nd that the number of ile ductules incr ased in NASH and correlated wi h portal inflammation and fibrosis [68].”
BackgroundInfluential
Cited by
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 218
Cholangiokines: undervalued modulators in the hepatic microenvironment
Cai, X., Tacke, F., Guillot, A., & Liu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192840 · Cited by 40
Rezvani, M., Vallier, L., & Guillot, A. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.01.014 · Cited by 34
The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
Shen, Q., Yang, M., Wang, S., Chen, X., Chen, S., Zhang, R., Xiong, Z., & Leng, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1374644 · Cited by 15
Metadata
- Authors
- Zhou, T., Kundu, D., Robles-Linares, J., Meadows, V., Sato, K., Baiocchi, L., Ekser, B., Glaser, S., Alpini, G., Francis, H., & Kennedy, L.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-08-12
- Volume
- 10
- Issue
- 8
- Pages
- 2072
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3188624255
- Cited by
- 23
- References
- 16
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.